RRF is essential for cell viability in bacteria, including E. coli, where it catalyzes ribosome dissociation from mRNA post-translation, enabling ribosomal subunits to reinitiate new rounds of translation . In E. coli, RRF depletion leads to:
While no direct studies on C. urealyticum RRF exist, its genome (2.37 Mbp, 64.2% GC content) shares structural features with other pathogenic corynebacteria, including three rrn operons and tRNA genes , suggesting conserved translation machinery.
C. urealyticum is a multidrug-resistant opportunist causing urinary tract infections (UTIs) with strong urease activity . While RRF itself is not directly linked to virulence, its role in translation efficiency could influence:
Antibiotic Resistance: Ribosome stalling due to impaired recycling may exacerbate resistance mechanisms (e.g., rpoB mutations conferring rifampicin resistance) .
Urease Production: Efficient translation of ureABC genes, critical for urea hydrolysis and struvite crystallization , may depend on RRF-mediated ribosome recycling.
Gene Identification: The frr gene in C. urealyticum has not been experimentally validated. Comparative genomics with E. coli and Corynebacterium jeikeium could clarify its sequence and regulation.
Recombinant Expression: No protocols for C. urealyticum RRF production exist. Successful RbfA expression in mammalian systems suggests feasibility.
Functional Studies: Ribosome profiling, as done in E. coli , could reveal post-termination ribosome behavior in C. urealyticum.
KEGG: cur:cu0821
STRING: 504474.cur_0821
Ribosome-recycling factor (frr) in C. urealyticum is responsible for the release of ribosomes from messenger RNA at the termination of protein biosynthesis. This 185-amino acid protein belongs to the RRF family and functions to increase translation efficiency by recycling ribosomes from one round of translation to another . Studies in other bacterial species, particularly Escherichia coli, have demonstrated that RRF is essential for cell growth and viability, with bacteria unable to survive without functional RRF .
The importance of RRF lies in its role in maintaining efficient protein synthesis, which is crucial for all cellular functions. While not a direct virulence factor like urease, RRF indirectly contributes to C. urealyticum pathogenicity by enabling the bacterium to synthesize proteins necessary for growth and the expression of actual virulence factors.
Production of recombinant C. urealyticum RRF for research purposes involves several key methodological steps:
Gene Synthesis and Cloning:
Expression System Selection:
E. coli-based systems (BL21(DE3), Rosetta strains) for basic expression
Consider alternative systems if protein folding issues occur:
Other bacterial hosts
Yeast expression systems
Insect cell systems for more complex proteins
Protein Expression:
Optimize induction conditions (temperature, inducer concentration, time)
Consider reduced temperatures (16-20°C) to enhance solubility
Implement auto-induction media for high-density cultures
Purification Strategy:
Cell lysis using sonication or pressure-based methods
Initial capture using affinity chromatography (based on fusion tag)
Secondary purification using ion exchange chromatography
Final polishing with size exclusion chromatography
Buffer optimization for protein stability
Quality Control:
SDS-PAGE for purity assessment
Mass spectrometry for identity confirmation
Circular dichroism for secondary structure verification
Activity assays to confirm functional integrity
This systematic approach ensures production of high-quality recombinant protein suitable for structural and functional studies.
C. urealyticum is primarily recognized as a urinary tract pathogen, with its pathogenicity strongly linked to specific molecular features:
Urease Activity:
Microbiological Characteristics:
Risk Factors for Infection:
While ribosome-recycling factor is essential for bacterial protein synthesis and survival , it contributes indirectly to pathogenicity by enabling bacterial growth and expression of virulence factors rather than acting as a virulence factor itself.
Investigating the specific role of RRF in C. urealyticum translation termination requires sophisticated experimental approaches:
In vitro Translation System Development:
Establish a reconstituted C. urealyticum translation system using:
Purified ribosomes
Translation factors (including RRF)
mRNAs with defined stop codons
Aminoacylated tRNAs
Monitor translation termination and ribosome recycling using:
Fluorescently labeled components for FRET analysis
Radioactively labeled amino acids for incorporation studies
Light scattering for ribosomal subunit dissociation measurements
Mutational Analysis Framework:
Create a systematic library of point mutations in conserved RRF residues
Express and purify these mutant proteins
Assess their activity in:
Ribosome binding assays
Ribosome recycling assays
Translation termination efficiency measurements
Create structure-function correlation maps
Ribosomal Complex Visualization:
Utilize cryo-electron microscopy to capture:
RRF binding to post-termination ribosomes
Conformational changes during ribosome recycling
Interactions with other translation factors (especially EF-G)
Compare structures at different stages of the recycling process
Single-Molecule Studies:
Apply single-molecule fluorescence techniques to observe:
Real-time binding kinetics of RRF to ribosomes
Conformational dynamics during recycling
Processivity of ribosome recycling
These complementary approaches would provide a comprehensive understanding of C. urealyticum RRF's specific role in translation termination and ribosome recycling.
Researchers working with recombinant C. urealyticum RRF face several technical challenges:
Codon Usage Optimization:
Challenge: C. urealyticum has high G+C content and different codon bias than E. coli
Solutions:
Synthesize codon-optimized gene for the expression host
Use specialized E. coli strains (Rosetta) expressing rare tRNAs
Consider C. glutamicum as an alternative expression host
Protein Solubility Issues:
Challenge: Recombinant RRF may form inclusion bodies
Solutions:
Lower induction temperature (16-20°C)
Use solubility-enhancing fusion tags (MBP, SUMO, thioredoxin)
Co-express with molecular chaperones (GroEL/ES, DnaK/J)
Optimize buffer conditions (pH, salt concentration, additives)
Protein Stability Concerns:
Challenge: RRF may show limited stability during purification
Solutions:
Include stabilizing agents in buffers:
Glycerol (10-20%)
Specific ions (Mg2+, K+)
Reducing agents (DTT, β-mercaptoethanol)
Perform rapid purification at 4°C
Identify and address protease-sensitive regions
Functional Verification Difficulties:
Challenge: Confirming native activity of recombinant protein
Solutions:
Develop specialized activity assays measuring:
Ribosome binding affinity
Ribosome recycling efficiency
Competition with native RRF
Compare activity parameters with RRF from well-characterized species
These methodological solutions provide a systematic approach to overcome technical hurdles in obtaining functionally active recombinant C. urealyticum RRF for research applications.
C. urealyticum RRF represents a potential antimicrobial target due to its essential role in bacterial protein synthesis. A comprehensive research strategy includes:
Target Validation Approaches:
Develop conditional RRF depletion systems in C. urealyticum
Demonstrate essentiality through growth inhibition upon depletion
Perform complementation studies with human translation factors
Establish minimum inhibitory RRF activity levels
High-Throughput Screening Platform:
Design biochemical assays measuring:
RRF binding to ribosomes
Ribosome recycling activity
EF-G GTPase stimulation by RRF
Adapt assays to microplate format with fluorescence or luminescence readouts
Screen compound libraries for inhibitory activity
Implement counter-screens to eliminate non-specific inhibitors
Structure-Based Drug Design:
Determine high-resolution structure of C. urealyticum RRF
Identify potential binding pockets using computational analysis
Compare with structures of human translation factors
Design compounds targeting C. urealyticum-specific features
Verify binding modes through co-crystallization studies
Antimicrobial Activity Evaluation:
Test promising compounds against:
C. urealyticum clinical isolates
Related Corynebacterium species
Other pathogens (to assess spectrum)
Mammalian cells (to assess selectivity)
Determine:
Minimum inhibitory concentrations (MIC)
Minimum bactericidal concentrations (MBC)
Time-kill kinetics
Resistance development frequency
This multifaceted approach could identify novel antimicrobial compounds targeting RRF, potentially addressing infections caused by multidrug-resistant C. urealyticum strains.
Investigating RRF-ribosome interactions requires sophisticated methodological approaches:
Ribosome Isolation and Complex Formation:
Purify intact C. urealyticum ribosomes through:
Differential ultracentrifugation
Sucrose gradient fractionation
Affinity chromatography
Generate defined ribosomal complexes:
Post-termination complexes (with deacylated tRNA)
Programmed ribosomes with specific mRNAs
Empty 70S ribosomes
Binding Kinetics Characterization:
Surface Plasmon Resonance (SPR):
Immobilize ribosomes on sensor chips
Flow RRF at varying concentrations
Determine kon, koff, and KD values
Analyze effects of mutations or inhibitors
Microscale Thermophoresis (MST):
Label RRF or ribosomes fluorescently
Monitor binding through thermophoretic mobility changes
Obtain precise binding constants under near-physiological conditions
Structural Analysis Methods:
Cryo-Electron Microscopy:
Prepare RRF-ribosome complexes
Collect high-resolution images (≤3Å)
Perform 3D reconstruction and refinement
Map interaction interfaces at near-atomic resolution
Chemical Cross-linking with Mass Spectrometry (XL-MS):
Use bifunctional cross-linkers to stabilize RRF-ribosome interactions
Digest cross-linked complexes
Identify cross-linked peptides through tandem mass spectrometry
Create distance constraint maps of interaction sites
Functional Assays:
Ribosome Recycling Efficiency:
Prepare post-termination complexes with dual-labeled subunits
Add RRF, EF-G, and GTP
Monitor subunit dissociation through FRET changes
Calculate recycling rates and efficiency
These advanced techniques provide complementary data on physical interactions, binding kinetics, and functional consequences of C. urealyticum RRF association with ribosomes.
The antimicrobial susceptibility profile of C. urealyticum presents important considerations for RRF research:
Known Susceptibility Patterns:
Implications for In Vitro Studies:
Selection of appropriate antibiotics for:
Maintenance of expression plasmids
Selective culture conditions
Contamination control in protein preparations
Potential confounding effects of antibiotics on:
Protein synthesis rates
Ribosome structure and function
RRF activity assessments
Research Opportunities:
Investigation of RRF's role in:
Antibiotic resistance mechanisms
Stress responses to antimicrobial exposure
Translation fidelity under antibiotic pressure
Antibiotic Combination Studies:
Exploration of synergistic effects between:
RRF inhibitors and conventional antibiotics
RRF inhibitors and urease inhibitors (targeting C. urealyticum's main virulence factor)
Methodological Considerations:
Growth medium supplementation:
For challenging clinical isolates
To prevent selection of resistant subpopulations
Optimization of expression systems:
Selection of appropriate antibiotic resistance markers
Consideration of induction methods compatible with C. urealyticum physiology
Understanding C. urealyticum's antimicrobial susceptibility profile enhances research design by informing practical laboratory approaches and identifying promising therapeutic combination strategies.
The relationship between RRF function and bacterial stress response in C. urealyticum represents an important research area:
Translation Regulation During Stress:
RRF likely plays a critical role in:
Recycling stalled ribosomes during stress conditions
Maintaining translation efficiency during nutrient limitation
Facilitating rapid protein synthesis changes in response to environmental shifts
Preventing ribosome sequestration on damaged mRNAs
Specialized Research Methodologies:
Ribosome Profiling During Stress:
Subject C. urealyticum to relevant stressors:
Urinary tract environmental conditions (pH shifts, urea concentration)
Antibiotic exposure (sub-inhibitory concentrations)
Nutrient limitation
Host immune factors
Sequence ribosome-protected mRNA fragments
Map ribosome positions genome-wide
Identify changes in translation patterns and efficiency
RRF Expression Analysis:
Quantify frr transcript levels under various stress conditions
Measure RRF protein abundance using quantitative proteomics
Determine if RRF undergoes post-translational modifications during stress
Integration with Stress Response Networks:
Investigate interactions between RRF and:
Stringent response mediators
Heat shock proteins
Cold shock proteins
Oxidative stress response factors
Experimental Model for Research:
| Stress Condition | Measurement Parameters | Expected RRF Response |
|---|---|---|
| Acid stress | Translation rate, Ribosome distribution, Cell viability | Potential increase in RRF activity to maintain translation |
| Antibiotic exposure | Ribosome stalling, Mistranslation rate, Growth recovery | RRF-mediated recycling of drug-stalled ribosomes |
| Nutrient starvation | Hibernating ribosome formation, Translation selectivity | Shift in RRF activity toward specific mRNA classes |
| Oxidative stress | Damaged ribosome clearance, Error rates | Enhanced RRF-mediated quality control |
This research direction could reveal how C. urealyticum adapts its translation machinery to survive in challenging environments, including during urinary tract infections and antimicrobial therapy.
Comparative analysis of RRF across bacterial species offers valuable insights:
Evolutionary Conservation Patterns:
Sequence Analysis Framework:
Align RRF sequences from diverse bacteria including:
Other Corynebacterium species
Clinically relevant pathogens
Model organisms with well-characterized RRFs
Calculate sequence identity and similarity percentages
Identify absolutely conserved residues versus variable regions
Map conservation onto structural models
Phylogenetic Analysis Approach:
Construct phylogenetic trees using maximum likelihood methods
Compare RRF evolution with species evolution
Identify potential horizontal gene transfer events
Correlate evolutionary patterns with ecological niches
Structure-Function Relationship Investigation:
Comparative Structural Analysis:
Generate homology models of C. urealyticum RRF
Compare with experimentally determined structures from other bacteria
Identify C. urealyticum-specific structural features
Predict functional implications of structural differences
Functional Cross-Complementation Studies:
Experimental Design:
Create RRF-depleted strains of model organisms (E. coli)
Complement with C. urealyticum RRF
Measure growth restoration and translation parameters
Identify species-specific functional requirements
Functional Domain Comparison:
| Domain/Region | C. urealyticum Features | Comparison with Other Bacteria | Functional Implications |
|---|---|---|---|
| Domain 1 (N-terminal) | [Specific structural elements] | Conservation level across bacteria | Role in ribosome binding |
| Domain 2 (C-terminal) | [Specific structural elements] | Variability across species | Species-specific adaptations |
| Interdomain linker | [Flexibility characteristics] | Conservation patterns | Importance for conformational changes |
| Ribosome binding interface | [Key residues] | Evolutionary pressure | Direct functional relevance |
This comparative approach provides a foundation for understanding both universal RRF functions and species-specific adaptations that may influence C. urealyticum pathogenesis and potential targeted therapeutics.
Investigating the effects of RRF inhibition requires a systematic experimental approach:
Genetic Manipulation Strategies:
Develop an Inducible RRF Depletion System:
Replace native frr promoter with inducible/repressible elements
Create partial knockdown strains with varying RRF levels
Establish complementation systems with wild-type or mutant RRF
CRISPR Interference Approach:
Target dCas9 to frr locus for transcriptional repression
Create tunable repression through inducible dCas9 expression
Monitor effects of partial vs. complete repression
Physiological Impact Assessment:
Growth and Viability Measurements:
Growth curves under various conditions
Minimum inhibitory concentration (MIC) determinations for various antibiotics
Persister cell formation frequency
Biofilm formation capacity
Cellular Ultrastructure Analysis:
Electron microscopy to visualize:
Ribosome distribution and abundance
Inclusion body formation
Membrane integrity
Nucleoid organization
Molecular Response Characterization:
Transcriptomic Response:
RNA-Seq analysis following RRF depletion
Identification of compensatory pathways
Stress response activation patterns
Changes in virulence factor expression
Proteomic Assessment:
Global proteome analysis using LC-MS/MS
Quantification of translation-related factors
Identification of proteins with altered abundance
Post-translational modification changes
Translation Quality Control Parameters:
Assessment of Translation Fidelity:
Mistranslation rates using reporter systems
Ribosome stalling frequency
Frameshifting and readthrough efficiency
Protein aggregation propensity
Experimental Data Framework:
| Parameter | Measurement Technique | Expected Outcome with RRF Inhibition |
|---|---|---|
| Growth rate | Optical density monitoring | Dose-dependent reduction |
| Ribosome status | Sucrose gradient analysis | Accumulation of post-termination complexes |
| Protein synthesis | 35S-methionine incorporation | Decreased global translation |
| Translation fidelity | Dual luciferase reporters | Increased error rates |
| Stress response | Transcriptome/proteome analysis | Activation of specific pathways |
This comprehensive approach would provide detailed insights into the physiological consequences of RRF inhibition, potentially identifying cascade effects that could be exploited for therapeutic intervention.